Pioglitazone and barriers to effective post-stroke comorbidity management in stroke survivors with diabetes

Hala Azhari; Jonathan Hewitt; Alexander Smith; Martin O’Neill; Terence Quinn; Jesse Dawson

doi:10.17712/nsj.2024.1.20230043

Article Information

vol. 29 no. 1 44-50

DOI

https://doi.org/10.17712/nsj.2024.1.20230043

PubMed

38195138

Published By

Neurosciences Journal

Online ISSN

1658-3183

History

Received May 31, 2023
Accepted November 20, 2023
Published online January 9, 2024.

Copyright: © Neurosciences Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

Hala Azhari, MD, MSc, PhD ⇑,
Jonathan Hewitt, MD, PhD,
Alexander Smith, MD, PhD,
Martin O’Neill, MD, PhD,
Terence Quinn, MD, PhD and
Jesse Dawson, MD, PhD

From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom

Address correspondence and reprint request to: Dr. Hala F. Azhari, Clinical Cardiovascular and Stroke Medicine, Clinical Pharmacology, College of Medicine and Pharmacy, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia. E-mail: hfazhari{at}uqu.edu.sa

View Full Text